Product information and disease descriptionPlace of product in therapyApproaches to treatment
Heterogeneity of treatment effect
2 evidence topics · 2 sources
STELLAR-303 overall-survival subgroup estimates at the initial reported analysis
| Subgroup | Hazard ratio and 95% confidence interval |
|---|---|
| RAS wild type | “0.79 (0.61-1.01)” |
| RAS mutant | “0.80 (0.66-0.98)” |